Clinical trial
Vapreotide in Treating Patients Undergoing Elective Pancreatic Resection
NCT00014651 · Mayo Clinic, Other · Terminated
Key facts
| NCT number | NCT00014651 |
|---|---|
| Title | Vapreotide in Treating Patients Undergoing Elective Pancreatic Resection |
| Official title | Vapreotide in Pancreas Surgery: A Double-Blind, Placebo-Controlled, Randomized Study of Vapreotide to Prevent Post-Surgical Complications in Patients Undergoing Elective Pancreatic Resection Grant Application Title: Vapreotide to Prevent Complications of Pancreatic Resection |
| Lead sponsor | Mayo Clinic, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Terminated |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Pancreatic Cancer, Perioperative/Postoperative Complications |
| Intervention type | Drug, Procedure |
| Interventions | vapreotide, conventional surgery |
| Start date | Mar 1, 2001 |
| Primary completion | Mar 1, 2001 |
| Completion | Apr 1, 2002 |
| First posted | May 5, 2004 |
| Last update posted | Aug 10, 2010 |
| Countries | United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: